Certified by Founder Lodge
Gradient Denervation Technologies
Switzerland - Basel
START UP
1 Disclosed Funding Rounds $15,015,000
0 Participating Investments
-
Founded date
2022
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
A solution for patients suffering from heart failure with pulmonary hypertension.
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| September, 08 ,2023 | Series A | $15,015,000 |
Sofinnova Partners
Asabys Partners
Thuja Capital
FundamentalVR
ForSight Robotics
HBOX Therapies
OXOS Medical
BioVentrix
Helex | $3,500,000 | (Nov 4, 2025)
xMEMS | $21,000,000 | (Nov 4, 2025)
catalyx space | $5,400,000 | (Nov 4, 2025)
Cephia AI | $4,000,000 | (Nov 4, 2025)
Ornn | $5,700,000 | (Nov 4, 2025)
